Apixaban or rivaroxaban in the treatment of acute venous thromboembolism?

Venous thromboembolism (VTE) may affects all parts of the venous circulation, but frequently manifests as deep vein thrombosis or pulmonary embolism. Annually, around 10 million cases are diagnosed worldwide, and VTE constitutes a growing global health burden with increasing incidence and prevalence (1,2). VTE is associated with substantial morbidity and mortality, and about 30% of all patients with VTE experience a recurrent event within 10...